Abstract
Renal dysfunction is a major complication in hemizygous males with Fabry disease. This often results in end-stage renal failure (ESRF), requiring dialysis or transplantation, on average 10 years after the start of renal impairment. ESRF usually occurs between 40 and 50 years of age, but may occur much earlier. Although progression of renal disease can be rapid, it is variable and may depend on whether there is residual α-galactosidase enzyme activity and on environmental or genetic factors. Significant renal disease is much less common in women carriers of the disease. However, renal changes do occur, which may progress to ESRF as in male patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Branton MH, Schiffmann R, Murray GJ, et al (2000) α-Galactosidase A activity influences renal disease course in Fabry disease. J Am Soc Nephrol 11: 403A (A2113).
Colombi A, Kostyal A, Bracher R, et al (1967) Angiokeratoma corporis diffusum-Fabry's disease. Helv Med Acta 34: 67–83.
Desnick RJ (2001) Fabry disease: clinical features and recent advances in enzyme replacement therapy. Adv Nephrol 31 (in press).
Grünfeld JP, Le Porrier M, Droz D, Bensaude I, Hinglais N, Crosnier J (1975) La transplantation rénale chez les sujets atteints de maladie de Fabry. Transplantation du rein d'un sujet hétérozyogote à un sujet sain. Nouv Presse Méd 4: 2081–2085.
Gubler MC, Lenoir G, Grünfeld JP, Ulmann A, Droz D, Habib R (1978) Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 13: 223–235.
Hillsley RE, Hernandez E, Steenbergen C, Bashore TM, Harrison JK (1995) Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease. Am Heart J 129: 199–202.
Maizel SE, Simmons RL, Kjellstrand C, Fryd DS (1981) Ten-year experience in renal transplantation for Fabry's disease. Transplant Proc 13: 57–59.
Muto H, Konoshita T, Nomura H, et al (2000) Fabry disease in patients with end-stage renal disease of unknown etiology. J Am Soc Nephrol 11: 411A.
Perdu J, Joly D, Lidove O (1998) Oedème pulmonaire aigu fébrile chez un hémodialysé. Méd Thérap 4: 675–680.
Popli S, Molnar, ZV, Leehey, et al (1987) Involvement of renal allograft by Fabry's disease. Am J Nephrol 7: 316–318.
Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ (2001) Coexistence of Fabry's disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol 55: 73–79.
US Renal Data System (2000) 2000 Annual Data Report. Transplantation. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease.
Tognoni, G (1996) ERA-EDTA Registry. Report on management of renal failure in Europe, XXVI, 1995. Nephrol Dial Transplant 11: 1–32.
Tsakiris D, Simpson HKL, Jones EHP, et al. (1996) Rare diseases in renal replacement therapy in the ERA-EDTA Registry. Nephrol Dial Transplant 11: 4–20.
Voglino A, Paradisi M, Dompe G, Onetti Muda A, Faraggiana T (1988) Angiokeratoma corporis diffusum (Fabry's disease) with unusual features in a female patient. Light-and electronmicroscopic investigation. Am J Dermatopathol 10: 343–348.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grünfeld, JP., Lidove, O., Joly, D. et al. Renal disease in Fabry patients. J Inherit Metab Dis 24 (Suppl 2), 71–74 (2001). https://doi.org/10.1023/A:1012475908718
Issue Date:
DOI: https://doi.org/10.1023/A:1012475908718